Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease

Kanbay M., Wolf M., Selcoki Y., Solak Y., IKIZEK M., Uysal S., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.44, sa.4, ss.1169-1175, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s11255-011-0076-x
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1169-1175
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). Recent data implicate disordered bone and mineral metabolism, including changes in serum levels of calcium, phosphate, parathyroid hormone (PTH), vitamin D, fibroblast growth factor-23 (FGF-23), and fetuin A, as novel risk factors for arterial calcification. The potential role of calcitonin, another hormonal regulator of mineral and bone metabolism, has not been studied in detail.